HLA-C and autoimmune disease: In both cases, we found that the predictive performance of Additive and Non-additive GenoBoost models are largely consistent (Supplementary Fig. 5, Supplementary Data 1, Supplementary Note 1), highlighting the unique ability of GenoBoost to incorporate non-additive genetic dominance effects at the MHC locus in improving genetic risk prediction of autoimmune diseases.